CSPC Pharmaceutical Group Ltd. (CVG) - Analysis

opens in 2d 10h 23m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.48 -0.11%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.67 0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.48 -0.11%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.67 0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.48 -0.11%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.67 0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,051.48 -0.11%
EUR/USD 1.15 0.02%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.67 0.02%
XPT/USD 1,003.20 0.33%

1.058500 EUR

0.0135

1.29%

Last update Apr 2, 7:30 PM CEST

Market closed

Day range

1.058500

1.044500

1.058500

Previous close

1.045000

Open

1.044500

Access this stock data via API

CSPC Pharmaceutical Group Ltd.

1.06

0.01

1.29%

Analysis

Analyst ratings

Firm	Date	Action
Barrington Research	Oct 17, 2017	Initiates
SunTrust Robinson Humphrey	Feb 15, 2017	Downgrade
Sidoti & Co.	Apr 04, 2016	Downgrade
Wells Fargo	Feb 25, 2016	Downgrade
Sidoti & Co.	Jan 06, 2016	Upgrade
Goldman Sachs	Jul 09, 2013	Upgrade
Oppenheimer	Aug 16, 2012	Downgrade
Stifel	Mar 23, 2012	Downgrade

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.